Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
St. |
RCV000761165 | SCV000891081 | uncertain significance | Hereditary diffuse gastric adenocarcinoma | 2020-09-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003303233 | SCV004007950 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-03-31 | criteria provided, single submitter | clinical testing | The p.R784P variant (also known as c.2351G>C), located in coding exon 15 of the CDH1 gene, results from a G to C substitution at nucleotide position 2351. The arginine at codon 784 is replaced by proline, an amino acid with dissimilar properties. This alteration was absent from 7,051 unselected female breast cancer patients and from 11,241 female controls of Japanese ancestry. In addition, it was not observed in unselected male breast cancer patients but was observed with an allele frequency of 0.0001 in 12,490 male controls of Japanese ancestry (Momozawa Y et al. Nat Commun, 2018 Oct;9:4083). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |